Literature DB >> 4080956

Subclinical chronic Q fever.

R J Fergusson, T R Shaw, A H Kitchin, M B Matthews, J M Inglis, J F Peutherer.   

Abstract

Seven patients are described in whom chronic Q fever was detected by serology (Coxiella burneti phase I antibody titre greater than 1:200) during routine screening at admission for cardiac catheterisation. None had clinical evidence of endocarditis, hepatitis or other foci of infection. Three of the patients were kept under observation without antibiotic treatment for periods of six, 18 and 20 months. In two patients of this group, cardiac tissue was obtained at operation and in one patient seroconversion following guinea-pig inoculation indicated the presence of Coxiella burneti infection. Four patients were given antibiotic treatment when Q fever was confirmed by serology. Courses of antibiotic treatment with a combination of two drugs were maintained for four to six years and in three of these patients phase I antibody titres fell to very low levels with no appearance of overt infection. The fourth patient died after resection of an aortic aneurysm, seven months after starting antibiotic treatment. Cases reported in the literature indicate that while endocarditis is the most common manifestation of chronic Q fever, the infection can persist at other sites. Of the seven cases of subclinical chronic Q fever reported here, the infection was localised in only one. Patients with this subclinical form of infection pose the therapeutic dilemma of whether or not they should receive antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4080956

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  8 in total

1.  Q fever in the United States: summary of case reports from two national surveillance systems, 2000-2012.

Authors:  F Scott Dahlgren; Jennifer H McQuiston; Robert F Massung; Alicia D Anderson
Journal:  Am J Trop Med Hyg       Date:  2014-11-17       Impact factor: 2.345

Review 2.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

4.  Isolation of Coxiella burnetii from heart valves of patients treated for Q fever endocarditis.

Authors:  K Mühlemann; L Matter; B Meyer; K Schopfer
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Reactivation of Q fever following cardiac surgery.

Authors:  T J Marrie; J Cunning; P Durnford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

6.  Chronic Q fever with mixed cryoglobulinaemia.

Authors:  H Torley; H Capell; M Timbury; C McCartney
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

7.  Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome.

Authors:  E Botelho-Nevers; P-E Fournier; H Richet; F Fenollar; H Lepidi; C Foucault; A Branchereau; P Piquet; M Maurin; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

8.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.